FIB‐4 as a prognostic model for patients with hepatitis B–associated hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|4|1325-1326

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.4, 2015-10, pp. : 1325-1326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FIB‐4 as a prognostic model for patients with hepatitis B–associated hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1325-1326

John Wiley & Sons Inc

Access to resources Recommend Favorite

High liver fibrosis index FIB‐4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers

By  

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1261-1268

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nucleos(t)ide analogues associated with a reduced risk of hepatocellular carcinoma in hepatitis B patients: A population‐based cohort study

By  

CANCER, Vol. 121, Iss. 9, 2015-05 ,pp. : 1446-1455

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single Nucleotide Polymorphisms Associated with Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection

By  

Intervirology, Vol. 48, Iss. 1, 2005-03 ,pp. : 10-15

Karger

Access to resources Recommend Favorite

The Molecular Diagnosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma

By Wong Chi-Hang   Chan Sophie   Chan Henry   Tsui Stephen  

Critical Reviews in Clinical Laboratory Sciences, Vol. 43, Iss. 1, 2006-01 ,pp. : 69-101

Informa Healthcare

Access to resources Recommend Favorite